REPORTING FROM THE EULAR 2018 CONGRESS
SOURCE: Smith B et al. EULAR 2018, Abstract No. SP0073.
© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
The findings challenge the Choosing Wisely campaign of the American Society of Nephrology, which recommends against NSAIDs for high-risk patients.
NEW ORLEANS – Know the disparate strengths and weaknesses of methadone, buprenorphine, and naltrexone for treating opioid addiction.
The short-acting drugs can complement methadone and buprenorphine to help patients get faster relief and help patients stay in the hospital to help with long-term management, say the authors of a new commentary.
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
